Antioxidative effects of thiazide diuretics in refractory hypertensive patients
A randomized crossover trial of chlortalidone and trichlo rmethiazide

Abstract

Some thiazide diuretics seem to exert antioxidant effects, which may be beneficial in the management of hypertension. Although many largescale clinical trial on hypertension have proved that thiazide diuretics confer significant reductions in stroke and cardiovascular events most of these trials preferentially used chlortalidone. Therefore, the difference in antioxidant effects between chlortalidone (CAS 77-36-1; 12.5 mg/day) and another thiazide diuretic, trichlormethiazide (CAS 133-67-5; 1 mg/day) was studied. Forty patients with refractory hypertension even after treatment with combination of a calcium channel blocker and an angiotensin II receptor blocke were randomly assigned to additionally receive either chlortalidone or trichlormethiazide for 6 months. Then, diuretic were switched in each patient and the were treated for another 6 months. Ambulatory blood pressure was monitored for 24 h and markers of inflammation (C-reactive protein) and oxidative stress (8-isoprostane, malondialdehyde-modified low-density lipoproteins) were measured before and after each treatment Addition of chlortalidone resulted in greater reduction of blood pressure (mean of 24 h; from 146.8 ± 18.0/83.8 ± 12.2 mmHg to 122 ± 18/72 ± 11 mmHg) than that of trichlormethiazide (134 ± 18/78 ± 11 mmHg, p < 0.001). The levels of C-reactive protein, malondialdehyde-modified low-density lipoproteins, and 8-isoprostane were lower after chlortalidone therapy than after trichlormethiazide therapy. These results suggest that chlortalidone is superior to trichlormethiazide in patients with essential hypertension.

Key word

Chlortalidone - 24 h ambulatory blood - pressure monitoring - Oxidative stress - Refractory hypertension - Thiazide diuretic - Trichlormethiazide

• Reference

• 1 The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002; 288: 2981-97
• 2 Wright Jr JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE et al. the ALLHAT Coolaborative Research Group. Outcomes in hypertensive black and nonblack patirnts treated with chlortalidone, amlodipine, and lisinopril. JAMA. 2005; 293: 1595-608
• 3 Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003; 289: 2534-44
• 4 Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979; 242: 2562-71
• 5 The Multiple Risk Factor Intervention Trial Research Group(MRFIT) Mortality rates after 10.5 years for hypertensive participants in the Multiple Risk Factor Intervension Trial. Circulation. 1990; 82: 1616-28
• 6 SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255-64
• 7 Neaton JD, Girmm Jr RH, Prineas RJ, Stamler J, Granditis GA, Elmer PJ et al. the Treatment of Mild Hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993; 270: 713-24
• 8 Joint National Committeeon Detection Evaluation Treatment of High Blood Pressure The Seventh report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). JAMA. 2003; 289: 2560-72
• 9 Skalska A, Gasowski J, Stepniewski M, Grodzicki T. Antioxidative protection in hypertensive patients treated with diuretics. Am J Hypertens. 2005; 18: 1130-2
• 10 Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003; 41: 1096-101
• 11 de Champlain J, Wu R, Girouard H, Karas M, El Midaoui A, Laplante MA et al. Oxidative stress in hypertension. Clin Exp Hypertens. 2004; 26: 593-601
• 12 Sato K, Dohi Y, Kojima M, Miyagawa K, Takase H, Katada E et al. Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung. 2006; 56: 535-40
• 13 Miyagawa K, Ohashi M, Yamashita S, Kojima M, Sato K, Ueda R et al. Increased oxidative stress impairs endothelial modulation of contractions in arteries from sponteously hypertensive rats. J Hypertens. 2007; 25: 415-21
• 14 Uehara Y, Kawabata Y, Shirahase H, Wada K, Hashizume Y, Morishita S et al. Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of Dahl strain rats. J Cardiovasc Pharmacol. 1993; 22 (06) S42-6
• 15 DellOmo G, Penno G, Prato SD, Pedrinelli R. Chlortalidone improves endothelial-mediated vascular responses in hypertension complicated by nondiabetic metabolic syndrome. J Cardiovasc Pharmacol Ther. 2005; 10: 265-72
• 16 Cooperative Study in Elderly Hypertensives Study. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension. 1999; 34: 1129-33
• 17 Rifai N, Tracy R, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 1999; 45: 2136-41
• 18 Kitano S, Kanno T, Maekawa M, Sakurabashi I, Kotani K, Hisatomi H et al. Improved method for the immunological detection of malondialdehyde-modified low-density lipoproteins in human serum. Anal Chim Acta. 2004; 509: 229-35
• 19 Walsh SW, Vaugham JE, Wang Y, Roberts II. LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000; 14: 1289-96
• 20 Boegehold MA. Flow-dependent arteriolar dilation in normotensive rats fed low or high-salt diets. Am J Physiol. Heart Circ Physiol. 1995; 269: H1407-14
• 21 Fujita T, Ito Y. Salt loads attenuate potassium-induced vasodilation of forearm vasculature in humans. Hypertension. 1993; 21: 772-8
• 22 Zhou MS, Schulman IH, Jaimes EA, Raij L. Thiazide diuretics endothelial function, and vascular oxidative stress. J Hypertens. 2008; 26: 494-500
• 23 Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R. Candesartan reduces oxidative stress and inflammation in patients with essential hypertension. Hypertens Res. 2003; 26: 691-7
• 24 Portaluppi F, Boari B, Manfredini R. Oxidative stress in essential hypertension. Curr Pharm Des. 2004; 10: 1695-8
• 25 Japanese Society of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009; 32: 3-107